Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:March 21, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:March 21, 2023Recruiting
Condition(s):Chronic Heart Failure With Reduced Ejection FractionLast Updated:November 3, 2022Recruiting
Condition(s):Heart Failure, Left Sided; Left Ventricular Dysfunction; Ventricular RemodelingLast Updated:May 28, 2020Completed
Condition(s):Heart Failure With Reduced Ejection Fraction; HyperkalemiaLast Updated:May 25, 2021Completed
Condition(s):Heart Failure; Reduced Ejection FractionLast Updated:December 9, 2022Recruiting
Condition(s):Acute Heart Failure With Reduced Ejection FractionLast Updated:September 22, 2022Terminated
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:February 8, 2023Not yet recruiting
Condition(s):Heart Failure With Mid Range Ejection FractionLast Updated:February 15, 2022Completed
Condition(s):Chronic Heart FailureLast Updated:August 16, 2021Not yet recruiting
Condition(s):Heart Failure With Reduced Ejection Fraction (HFrEF); Dilated CardiomyopathyLast Updated:November 8, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.